Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	51.79	99.19	102.99	100.71	184.43	143.58
Short-Term Investments	499.05	578.28	292.74	268.39	183.36	171.91
Cash & Short-Term Investments	550.84	677.46	395.73	369.1	367.79	315.49
Cash Growth	158.15%	71.19%	7.21%	0.36%	16.58%	21.95%
Receivables	2.5	-	-	1.41	10.26	0.85
Prepaid Expenses	9.37	9.54	8.81	7.29	4.36	4.25
Restricted Cash	2.1	3.5	7.9	7.3	-	-
Other Current Assets	5.74	4.97	4.03	20.2	2.19	1.78
Total Current Assets	570.54	695.47	416.47	405.3	384.6	322.37
Property, Plant & Equipment	431.94	431.29	335.56	168.59	66.02	47.02
Long-Term Investments	-	-	-	105.87	245.6	137.49
Other Intangible Assets	8.14	8.56	10.26	11.96	13.66	15.36
Other Long-Term Assets	3.08	4.48	3.26	0.22	0.27	0.26
Total Assets	1,014	1,140	765.55	691.94	710.15	522.5
Accounts Payable	14.46	11.39	35.87	2.87	9.46	6.83
Accrued Expenses	68.1	80.8	43.68	59.11	23.77	13.45
Current Portion of Long-Term Debt	1.63	-	-	-	-	-
Current Portion of Leases	6.56	6.34	10.56	2.78	2.25	1.1
Current Unearned Revenue	-	-	0.87	74.1	111.06	19.29
Other Current Liabilities	3.01	4.64	14.48	-	-	0.02
Total Current Liabilities	93.76	103.17	105.46	138.85	146.54	40.68
Long-Term Debt	754.57	734.54	268.33	-	-	-
Long-Term Leases	109.3	111.03	104.61	78.8	23.3	20.04
Long-Term Unearned Revenue	-	-	-	55.95	131.5	-
Total Liabilities	957.62	948.74	478.39	273.6	301.33	60.73
Common Stock	0.22	0.22	0.2	0.2	0.2	0.2
Additional Paid-In Capital	1,847	1,806	1,300	1,219	1,053	965.41
Retained Earnings	-1,799	-1,626	-1,026	-820.76	-644.69	-503.84
Comprehensive Income & Other	4.14	4.75	-3.22	-0.14	-0.07	0.02
Total Common Equity	52.59	185.44	271.34	398.52	408.82	461.78
Minority Interest	3.49	5.62	15.82	19.82	-	-
Shareholders' Equity	56.08	191.06	287.16	418.34	408.82	461.78
Total Liabilities & Equity	1,014	1,140	765.55	691.94	710.15	522.5
Total Debt	872.05	851.91	383.5	81.58	25.55	21.14
Net Cash (Debt)	-321.21	-174.45	12.23	287.52	342.24	294.36
Net Cash Growth	-	-	-95.75%	-15.99%	16.27%	13.78%
Net Cash Per Share	-2.59	-1.46	0.11	2.73	3.30	2.92
Filing Date Shares Outstanding	126.1	124.43	107.43	106.01	104.53	102.76
Total Common Shares Outstanding	125.57	124.38	107.31	105.96	104.33	102.38
Working Capital	476.78	592.3	311.02	266.45	238.06	281.69
Book Value Per Share	0.42	1.49	2.53	3.76	3.92	4.51
Tangible Book Value	44.45	176.88	261.08	386.56	395.16	446.42
Tangible Book Value Per Share	0.35	1.42	2.43	3.65	3.79	4.36
Land	3	3	3	3	-	-
Buildings	238.78	75.99	-	-	-	-
Machinery	78.06	71.93	58.75	40.47	29.67	21.32
Construction In Progress	25.66	188.73	166.66	56.37	0.35	-
Leasehold Improvements	104.39	104.41	103.81	42.02	41.52	25.24

Source: S&P Capital IQ. Standard template. Financial Sources.